Avelumab (MSB0010718C; anti-PD-LI) in patients with advanced gastric or gastroesophageal junction cancer from JAVELIN solid tumor phase Ib trial: Analysis of safety and clinical activity

This article has no abstract
Epistemonikos ID: 5277123219f72465418891a61dbfb1c3e3b373ef
First added on: Feb 07, 2025